Socialiya - Entertainment. Knowledge. Community.
Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial

Pfizer's high-stakes bet on antibody-drug conjugates (ADCs) has hit a speed bump. The pharma giant a...

BUSINESS NEWS June 23, 2026

Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial

Pfizer's high-stakes bet on antibody-drug conjugates (ADCs) has hit a speed bump. The pharma giant announced Monday that sigvotatug vedotin, the first new...

2 views 0 likes 0 comments
Share:
Pfizer's high-stakes bet on antibody-drug conjugates (ADCs) has hit a speed bump. The pharma giant announced Monday that sigvotatug vedotin, the first new...

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
socialiya
Advertisement
APNA POS
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya